Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

NovaShunt (Switzerland) a clinical-stage medical device company focused on an implantable ascites pump system for patients suffering from liver cirrhosis, certain cancers and congestive heart failure, closed a $25M Series B financing. Participants include BioMedInvest, Entrepreneurs Fund, Capricorn Health-tech Fund, NeoMed and VI Partners.

Tandem Diabetes Care (San Diego, CA) a development-stage medical device company focused on insulin pump technology, closed a $30.8M Series C financing, bringing the total round to $52.3M. Participants include HLM Venture Partners, Domain Associates, TPG Biotech, Delphi Ventures and Kearny Venture Partners.

InSet Technologies (Mt. Olive, NJ) an early-stage company developing implantable pumps delivering targeted medications directly to the spinal cord (intrathecal space) to achieve potentially improved functional relief with a dramatic reduction in the side effects from high doses of drugs for chronic pain, closed a $25M Series B financing. Participants include Clarus Ventures and FatBoy […]

  

to top of page...